Literature DB >> 30763038

Medication adherence as a measure of the quality of care provided by physicians.

Seth A Seabury1, J Samantha Dougherty, Jeff Sullivan.   

Abstract

OBJECTIVES: To assess the extent to which medication adherence in congestive heart failure (CHF) and diabetes may serve as a measure of physician-level quality. STUDY
DESIGN: A retrospective analysis of Medicare data from 2007 to 2009, including parts A (inpatient), B (outpatient), and D (pharmacy).
METHODS: For each disease, we assessed the correlation between medication adherence and health outcomes at the physician level. We controlled for selection bias by first regressing patient-level outcomes on a set of covariates including comorbid conditions, demographic attributes, and physician fixed effects. We then classified physicians into 3 levels of average patient medication adherence-low, medium, and high-and compared health outcomes across these groups.
RESULTS: There is a clear relationship between average medication adherence and patient health outcomes as measured at the physician level. Within the diabetes sample, among physicians with high average adherence and controlling for patient characteristics, 26.3 per 1000 patients had uncontrolled diabetes compared with 45.9 per 1000 patients among physicians with low average adherence. Within the CHF sample, also controlling for patient characteristics, the average rate of CHF emergency care usage among patients seen by physicians with low average adherence was 16.3% compared with 13.5% for doctors with high average adherence.
CONCLUSIONS: This study's results establish a physician-level correlation between improved medication adherence and improved health outcomes in the Medicare population. Our findings suggest that medication adherence could be a useful measure of physician quality, at least for chronic conditions for which prescription medications are an important component of treatment.

Entities:  

Mesh:

Year:  2019        PMID: 30763038

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  5 in total

1.  The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint.

Authors:  Przemyslaw Kardas; Isabel Aguilar-Palacio; Marta Almada; Caitriona Cahir; Elisio Costa; Anna Giardini; Sara Malo; Mireia Massot Mesquida; Enrica Menditto; Luís Midão; Carlos Luis Parra-Calderón; Enrique Pepiol Salom; Bernard Vrijens
Journal:  J Med Internet Res       Date:  2020-08-27       Impact factor: 5.428

2.  Examining the Drivers of Racial/Ethnic Disparities in Non-Adherence to Antihypertensive Medications and Mortality Due to Heart Disease and Stroke: A County-Level Analysis.

Authors:  Macarius M Donneyong; Michael A Fischer; Michael A Langston; Joshua J Joseph; Paul D Juarez; Ping Zhang; David M Kline
Journal:  Int J Environ Res Public Health       Date:  2021-12-02       Impact factor: 3.390

Review 3.  Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges.

Authors:  Przemysław Kardas; Martina Bago; Pilar Barnestein-Fonseca; Kristina Garuolienė; Anne Gerd Granas; João Gregório; Maja Ortner Hadžiabdić; Barbora Kostalova; Francisca Leiva-Fernández; Pawel Lewek; Katerina Mala-Ladova; Marie Paule Schneider; Job F M van Boven; Daisy Volmer; Ioli Ziampara; Tamás Ágh
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

4.  Adherence and the Moral Construction of the Self: A Narrative Analysis of Anticoagulant Medication.

Authors:  Meredith K D Hawking; John Robson; Stephanie J C Taylor; Deborah Swinglehurst
Journal:  Qual Health Res       Date:  2020-08-28

5.  Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment.

Authors:  Macarius M Donneyong; Teng-Jen Chang; John W Jackson; Michael A Langston; Paul D Juarez; Shawnita Sealy-Jefferson; Bo Lu; Wansoo Im; R Burciaga Valdez; Baldwin M Way; Cynthia Colen; Michael A Fischer; Pamela Salsberry; John F P Bridges; Darryl B Hood
Journal:  Int J Environ Res Public Health       Date:  2020-09-14       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.